Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what estimate his Department has made of the cost of treating a baby with group B streptococus infection.
Public Health England have been collaborating with researchers in Cambridge on a study assessing the potential cost-effectiveness of maternal group B streptococcus (GBS) vaccination in anticipation of a vaccine becoming available in the coming years. As part of this assessment, the cost of treatment of infants with GBS infection is being evaluated and will be available at the conclusion of the study.